- Easy Tracking In The Watchlist
Tnf Pharmaceuticals, Inc. Common Stock stock price ended at $3.87 on Friday, after gaining 1.31%
(Updated on Jun 12, 2026)
The Tnf Pharmaceuticals, Inc. Common Stock stock price gained 1.31% on the last trading day (Friday, 12th Jun 2026), rising from $3.82 to $3.87. During the last trading day the stock fluctuated 5.54% from a day low at $3.79 to a day high of $4.00. The price has fallen in 6 of the last 10 days and is down by -11.44% for this period. Volume fell on the last day by -72 thousand shares and in total, 186 thousand shares were bought and sold for approximately $718.69 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.58 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 8.51% during the next 3 months and, with a 90% probability hold a price between $3.89 and $5.71 at the end of this 3-month period.
QCLS Signals & Forecast
There are few to no technical positive signals at the moment. The Tnf Pharmaceuticals, Inc. Common Stock stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $3.97. On a fall, the stock will find some support from the short-term average at $3.78. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Thursday, May 14, 2026, and so far it has fallen -24.56%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Support, Risk & Stop-loss for Tnf Pharmaceuticals, Inc. Common Stock stock
Tnf Pharmaceuticals, Inc. Common Stock finds support from accumulated volume at $3.80 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.210 between high and low, or 5.54%. For the last week the stock has had daily average volatility of 6.58%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (QCLS) For The Upcoming Trading Day Of Monday 15th
For the upcoming trading day on Monday, 15th we expect Tnf Pharmaceuticals, Inc. Common Stock to open at $3.89, and during the day (based on 14 day Average True Range), to move between $3.69 and $4.05, which gives a possible trading interval of +/-$0.354 (+/-9.60%) up or down from last closing price. If Tnf Pharmaceuticals, Inc. Common Stock takes out the full calculated possible swing range there will be an estimated 9.60% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $3.94 (1.81%) than the support at $3.80 (1.81%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Tnf Pharmaceuticals, Inc. Common Stock stock A Buy?
The Tnf Pharmaceuticals, Inc. Common Stock stock holds several negative signals and despite the positive trend, we believe Tnf Pharmaceuticals, Inc. Common Stock will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
Current score:
-4.643
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 15, 2026 - $3.89 ( 0.431%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
QCLS Performance
Trading levels for QCLS
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 4.10 | 5.86% |
| R2 | 4.02 | 3.78% |
| R1 | 3.97 | 2.50% |
| Price | 3.87 | |
| S1 | 3.81 | -1.64% |
| S2 | 3.76 | -2.92% |
| S3 | 3.68 | -5.00% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 4.18 | 8.01% |
| R2 | 4.00 | 3.36% |
| R1 | 3.94 | 1.81% |
| Price | 3.87 | |
| S1 | 3.80 | -1.81% |
| S2 | 3.79 | -2.07% |
| S3 | 3.70 | -4.39% |
FAQ
Click here for our free guide on how to buy Tnf Pharmaceuticals, Inc. Common Stock Stock.
Buy QCLS